Earnings Outlook For The Oncology Institute
Portfolio Pulse from Benzinga Insights
The Oncology Institute (NASDAQ:TOI) is expected to report a quarterly EPS of $-0.11 on March 27, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, TOI's stock price has shown significant movement post-earnings announcement, with a notable 27.72% increase after last quarter's miss. Over the last year, TOI shares have surged by 150.5%, indicating strong long-term shareholder satisfaction.
March 26, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The Oncology Institute is anticipated to report a quarterly EPS of $-0.11, with investors keen on an earnings beat and positive future guidance. The stock has historically reacted to earnings announcements, and shares have significantly appreciated over the past year.
Given TOI's history of stock price movement post-earnings and the overall positive trend in the past year, there's a high likelihood of a positive short-term impact if the company beats the EPS estimate and provides favorable guidance. The anticipation of this event, based on past performance, suggests a potential increase in stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100